https://www.selleckchem.com/pr....oducts/fen1-in-4.htm
An estimated 250 million people worldwide are chronically infected with hepatitis B virus (HBV), the leading cause of hepatocellular carcinoma (HCC) globally. The novel virus continues to spread at an alarming rate, and with guidance at the onset of the pandemic recommending the deferral of HCC surveillance, the implications on liver cancer care are now emerging and highlight the urgent need for reorganisation of services. We analysed how five HCC risk prediction scores could aid stratification of patients with chronic HBV. We calcula
Like
Comment
Share
